Diabetes Journal Articles and Videos
Treatment Options for Pediatric Diabetes
US Endocrinology. 2018;14(1):20–21 DOI: https://doi.org/10.17925/USE.2018.14.1.20
US Endocrinology. 2018;14(1):27–29 DOI: https://doi.org/10.17925/USE.2018.14.1.27
The GlucoCoper—A Salutogenic Approach to Diabetes Distress
US Endocrinology, 2018;14(1):30–31 DOI: https://doi.org/10.17925/USE.2018.14.1.30
Women with Diabetes—Two Specifications Mean Double Trouble
US Endocrinology, 2018;14(1):32–34 DOI: https://doi.org/10.17925/USE.2018.14.1.32
Institute of Metabolism and Systems Research (IMSR), University of Birmingham, and Centre of Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Abd Tahrani is a National Institute for Health Research (NIHR) Clinician Scientist at the University of Birmingham (UOB), and a Honorary Consultant Endocrinologist at the University Hospitals Birminghan NHS Foundation Trust; and the lead for weight management research and diabetic neuropathy services at Birmingham Heartlands Hospital, Birmingham, UK. He gained MD in 1998, MRCP (UK) in 2003, MMedSci from Keele University in 2008, CCT in Diabetes & Endocrinology in 2012 and a PhD in 2013 from the UOB.
Dr. Tahrani has published over 125 peer reviewed articles and book chapters and in excess of 150 abstracts. He was invited to speak in the leading national and international conferences in the fields of Obesity, Diabetes, Endocrinology, and Sleep medicine including Endo (USA), the American Diabetes Association (ADA), SLEEP (USA), NeuroDiab (the Neuropathy group of the EASD), the Young Diabetologist Forum (YDF), the British Endocrine Societies (BES), The World Obesity Federation SCOPE school, The EASDec (The retinopathy group of the EASD), RCP (London), RCSP (Glasgow), the Greek Obesity Society and several other conferences in Asia and Europe. His main research themes are: obesity management and treatment (including bariatric surgery), the metabolic consequences of sleep-related disorders in patients with diabetes and/or obesity, the pathogenesis of diabetes-related microvascular complications (particularly neuropathy and nephropathy), and the pharmacology of type 2 diabetes.
Dr. Tahrani has won several national and international awards including SCOPE National Fellow from the World Obesity Federation in 2014, The Diabetes UK best primary care poster award 2014, NIHR Clinician Scientist award in 2013, the American Academy of Sleep Medicine Sleep Disordered Breathing investigator of the year award in 2013, The Sanofi Aventis Clinical Excellence Award in 2009, the Society for endocrinology presentations award 2009, and a NIHR personal fellowship in 2008 amongst others. He was also nominated to the Nick Hales young investigator award by Diabetes UK.
He is currently the diabetes and metabolism section editor for BMC Endocrine disorders and an editorial advisor to BMC Obesity. He is the Editor-in-Chief for European Endocrinology. He serves on the editorial boards of several journals and was the editorial consultant for the type 1 diabetes module of the American College of Physicians. He is a grant reviewer to NIHR grant streams, the Hong Kong research council, Diabetes UK, The Novo Nordisk Research Foundation, the MRC, the BBSRC, and the New Zealand research council amongst others. Dr Tahrani is a regular peer reviewer to several leading journals including: the Lancet, Lancet Diabetes & Endocrinology, Annals of internal Medicine, BMJ, Journal of American College of Cardiology, Diabetes care, Diabetologia, Diabetic Medicine, European Journal of Endocrinology, Clinical Endocrinology and many others.
Dr. Tahrani is included the Who’s Who in the world directory, his research was highlighted on many scientific and news websites. Dr. Tahrani is an examiner at the Royal College of Physicians and has served on the clinical committee of the Society of Endocrinology. Dr Tahrani also served as an expert advisor to NICE.
Professor of Medicine, Catholic University Leuven
Dr. Mathieu’s basic research interest is in prevention of Type 1 diabetes and non-classical effects of Vitamin D.
Dr. Mathieu has authored more than 300 articles in peer reviewed journals and was Associate editor and a member of the Advisory Board for Diabetologia. She is a member of the Research Council of Flanders and is a member of the European Association for the Study of Diabetes, the American Diabetes Association, IDS and former President of the Flemish Diabetes Association.
Linda Siminerio, RN, PhD, CDE
Executive Director, University of Pittsburgh Diabetes Institute
Dr. Siminerio’s primary research topics include diabetes education, diabetes translation into community interventions, pediatric diabetes care and education, and the psychosocial and behavioral aspects of diabetes.
Dr. Siminerio is the author of numerous books and scientific publications in her field and is the author of the National Standards for Diabetes Education and the International Diabetes Standards and Curriculum.
She is a nationally prominent advocate for diabetes care, education and funding, and is a former Vice President of the ADA. She is the Chair of the International Diabetes Federation (IDF) translation research program and served as Chair of the IDF World Congress.
Video List based on Category on Node Page
The touchENDOCRINOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of endocrinology:
Katrina Mountfort, Senior Medical Writer, Touch Medical Media, UK
-Insights into recent CVOTs, discussed at the ADA, 77th Scientific Sessions, San Diego, CA, June 11th 2017
Jeremy Betts, Account Director and Advisory Editor, Touch Medical Media, UK
-Insights into STAMPEDE clinical trial from the Cleveland Clinic, presented at AACE, Boston, US, 16–20 May 2018
Matthew Goodwin, Group Director and Advisory Editor, Touch Medical Media, UK
-Insights into toe-brachial index in Diabetes, presented at ECE, Barcelona, Spain, 19–22 May 2018